Development of a Knowledge Management Center for Illuminating the Druggable GenomeTitle Here (U54)

The summary for the Development of a Knowledge Management Center for Illuminating the Druggable GenomeTitle Here (U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of a Knowledge Management Center for Illuminating the Druggable GenomeTitle Here (U54): This Funding Opportunity Announcement (FOA) is a part of the new NIH Common Fund program, Illuminating the Druggable Genome (IDG). The goal of this program is to increase the understanding of the properties and functions of poorly characterized and/or un-annotated proteins within four of the most commonly drug-targeted protein families. The IDG will include two components, the Knowledge Management Center (KMC, to be supported under this FOA) and the Technology Development Initiative (to be supported under a companion FOA, RFA-RM-13-010).
Federal Grant Title: Development of a Knowledge Management Center for Illuminating the Druggable GenomeTitle Here (U54)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-13-011
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.310
CFDA Descriptions: Trans-NIH Research Support
Current Application Deadline: Dec 11, 2013
Original Application Deadline: Dec 11, 2013
Posted Date: Sep 16, 2013
Creation Date: Sep 16, 2013
Archive Date: Jan 11, 2014
Total Program Funding: $3,000,000
Maximum Federal Grant Award: $3,000,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public and State controlled institutions of higher education
Additional Information on Eligibility
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-011.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Using Metabolomics to Investigate Biological Pathways and Networks (R01)
Assay Development for High Throughput Molecular Screening (R21)
Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com